4-147521854-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001957.4(EDNRA):c.548+1876C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.113 in 152,160 control chromosomes in the GnomAD database, including 1,040 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.11   (  1040   hom.,  cov: 32) 
Consequence
 EDNRA
NM_001957.4 intron
NM_001957.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -1.05  
Publications
1 publications found 
Genes affected
 EDNRA  (HGNC:3179):  (endothelin receptor type A) This gene encodes the receptor for endothelin-1, a peptide that plays a role in potent and long-lasting vasoconstriction. This receptor associates with guanine-nucleotide-binding (G) proteins, and this coupling activates a phosphatidylinositol-calcium second messenger system. Polymorphisms in this gene have been linked to migraine headache resistance. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009] 
EDNRA Gene-Disease associations (from GenCC):
- mandibulofacial dysostosis with alopeciaInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
 - cystic fibrosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91). 
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.242  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.113  AC: 17169AN: 152044Hom.:  1043  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
17169
AN: 
152044
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.113  AC: 17162AN: 152160Hom.:  1040  Cov.: 32 AF XY:  0.116  AC XY: 8659AN XY: 74392 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
17162
AN: 
152160
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
8659
AN XY: 
74392
show subpopulations 
African (AFR) 
 AF: 
AC: 
3779
AN: 
41536
American (AMR) 
 AF: 
AC: 
1650
AN: 
15284
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
458
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
996
AN: 
5184
South Asian (SAS) 
 AF: 
AC: 
1223
AN: 
4814
European-Finnish (FIN) 
 AF: 
AC: 
1253
AN: 
10548
Middle Eastern (MID) 
 AF: 
AC: 
38
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
7456
AN: 
68006
Other (OTH) 
 AF: 
AC: 
229
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.499 
Heterozygous variant carriers
 0 
 770 
 1540 
 2309 
 3079 
 3849 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 212 
 424 
 636 
 848 
 1060 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
773
AN: 
3474
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.